Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 3
Submit an article Journal homepage
1,561
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Oncolytic viruses sensitize human tumor cells for NY-ESO-1 tumor antigen recognition by CD4+ effector T cells.

Tiphaine DelaunayCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
,
Mathilde ViollandCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
,
Nicolas BoisgeraultCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
,
Soizic DutoitCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
,
Virginie VignardCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
,
Christian MünzInstitute of Experimental Immunology, University of Zürich, SwitzerlandView further author information
,
Monique GannageInstitute of Experimental Immunology, University of Zürich, Switzerland;School of Medicine, University of Geneva, SwitzerlandView further author information
,
Brigitte DrénoCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, France;Dermatology Department, Nantes Hospital, Nantes, FranceView further author information
,
Kristine VaivodeLatvian Biomedical Research and Study Centre, Riga, LatviaView further author information
,
Dace PjanovaLatvian Biomedical Research and Study Centre, Riga, LatviaView further author information
,
Nathalie LabarrièreCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
,
Yaohe WangCentre for Molecular Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK;National Centre for International Research in Cell and Gene Therapy, Sino-British Research Centre for Molecular Oncology, Zhengzhou University, ChinaView further author information
,
E. Antonio ChioccaHarvey Cushing Neuro-Oncology Laboratories, Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USAView further author information
,
Fabrice Le BoeufCenter for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada;University of Ottawa, Ottawa, CanadaView further author information
,
John C. BellCenter for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Canada;University of Ottawa, Ottawa, CanadaView further author information
,
Philippe ErbsTransgene, Illkirch, FranceView further author information
,
Frédéric TangyUnité de Génomique Virale et Vaccination, Institut Pasteur, CNRS UMR-3569, Paris, FranceView further author information
,
Marc GrégoireCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceView further author information
&
Jean-François FonteneauCRCINA, INSERM, Université d'Angers, Université de Nantes, Nantes, France;Labex IGO, Immunology Graft Oncology, Nantes, FranceCorrespondence[email protected]
View further author information
 show all
Article: e1407897 | Received 09 Jun 2017, Accepted 15 Nov 2017, Published online: 26 Dec 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Jonathan G. Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Boeuf, Derek R. Clements, Jean-Eudes Fahrner, Laetitia Fend, John C. Bell, Karen L. Mossman, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology 7:12.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.